Literature DB >> 16814532

pH-independent pulsatile drug delivery system based on hard gelatin capsules and coated with aqueous dispersion Aquacoat ECD.

Ahmad Mohamad1, Andrei Dashevsky.   

Abstract

The objective of this study was to develop a rupturable, capsule-based pulsatile drug delivery system with pH-independent properties prepared using aqueous coating. The drug release is induced by rupturing of the top-coating, resulting by expanding of swellable layer upon water penetration through the top-coating. Croscarmellose sodium (AcDiSol) is a preferable superdisintegrant compared to low substituted hydroxypropylcellulose (L-HPC) and sodium starch glycolate (Explotab), because of controlled lag time, followed by a quick and complete drug release. However, due to its anionic character, AcDiSol showed pH-dependent swelling characteristics (pH 7.4 > 0.1N HCl) resulting in a pH-dependent lag time. The pH dependency could be eliminated by the addition of fumaric acid to the swelling layer, which allowed to keep an acidic micro-environment. Formation of the rupturable top-coating was successfully performed using an aqueous dispersion of ethylcellulose (Aquacoat) ECD), whereby sufficient drying during the coating was needed to avoid swelling of the AcDiSol layer. A higher coating level was required, when aqueous dispersion was used, compared to organic coatings. However, an advantageous aspect of the aqueous coating was the lower sensitivity of the lag time to a deviation in the coating level.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16814532     DOI: 10.1016/j.ejpb.2006.04.006

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  1 in total

1.  Intelligently targeted drug delivery and enhanced antitumor effect by gelatinase-responsive nanoparticles.

Authors:  Rutian Li; Wei Wu; Qin Liu; Puyuan Wu; Li Xie; Zhenshu Zhu; Mi Yang; Xiaoping Qian; Yin Ding; Lixia Yu; Xiqun Jiang; Wenxian Guan; Baorui Liu
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.